DK90589D0 - Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom - Google Patents

Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom

Info

Publication number
DK90589D0
DK90589D0 DK090589A DK90589A DK90589D0 DK 90589 D0 DK90589 D0 DK 90589D0 DK 090589 A DK090589 A DK 090589A DK 90589 A DK90589 A DK 90589A DK 90589 D0 DK90589 D0 DK 90589D0
Authority
DK
Denmark
Prior art keywords
chymotrypsin
preparations
preekallikrein
make
immobilised
Prior art date
Application number
DK090589A
Other languages
English (en)
Other versions
DK90589A (da
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK90589D0 publication Critical patent/DK90589D0/da
Publication of DK90589A publication Critical patent/DK90589A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK090589A 1988-02-26 1989-02-24 Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom DK90589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0049488A AT391810B (de) 1988-02-26 1988-02-26 Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Publications (2)

Publication Number Publication Date
DK90589D0 true DK90589D0 (da) 1989-02-24
DK90589A DK90589A (da) 1989-08-27

Family

ID=3492093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK090589A DK90589A (da) 1988-02-26 1989-02-24 Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom

Country Status (9)

Country Link
US (2) US5094949A (da)
EP (1) EP0330647B1 (da)
JP (1) JPH07116052B2 (da)
AT (2) AT391810B (da)
CA (1) CA1338499C (da)
DE (1) DE58905495D1 (da)
DK (1) DK90589A (da)
ES (1) ES2059826T3 (da)
FI (1) FI93696C (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
WO2004047859A2 (en) * 2002-11-25 2004-06-10 Octapharma Ag Prekallikrein depleted plasma derived albumin fraction
ES2221817B1 (es) * 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU469815B2 (en) * 1971-04-14 1973-10-18 Anti-inflammatory compositions
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4608253A (en) * 1982-05-31 1986-08-26 Mochida Pharmaceutical Co., Ltd. Process for removing immune complex in blood by use of the immobilized pepsin
AT376367B (de) * 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Also Published As

Publication number Publication date
FI890907A0 (fi) 1989-02-24
CA1338499C (en) 1996-07-30
ATE94071T1 (de) 1993-09-15
FI890907A (fi) 1989-08-27
EP0330647A2 (de) 1989-08-30
DE58905495D1 (de) 1993-10-14
EP0330647A3 (en) 1990-05-09
US5094949A (en) 1992-03-10
FI93696B (fi) 1995-02-15
AT391810B (de) 1990-12-10
DK90589A (da) 1989-08-27
ES2059826T3 (es) 1994-11-16
US5324628A (en) 1994-06-28
ATA49488A (de) 1990-06-15
JPH01261332A (ja) 1989-10-18
FI93696C (fi) 1995-05-26
EP0330647B1 (de) 1993-09-08
JPH07116052B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
DK0431129T3 (da) Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
MX9203370A (es) Desulfatohirudina y composiciones farmaceuticas que la contienen.
ES2051897T3 (es) Genes clonados que codifican proteinas de fusion ig-cd4 y su uso.
NO166303C (no) Fremgangsmaate ved kvantitativ bestemmelse av protein c ogaktivatorpreparat til gjennomfoering av fremgangsmaaten.
ATA117890A (de) Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DK90589D0 (da) Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DK3689A (da) Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsvaekkere i blodplasmaprodukter
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
ATE124539T1 (de) Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
DK131284D0 (da) Fremgangsmaade til inaktivering af stoffer,der foraarsager uforenelighedsreaktioner
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
NO173831C (no) Nye monoklonale antistoffer mot IFN-omega, hybridomer til fremstilling derav og anvendelse for rensing samt paavisning eller kvantitativ bestemmelse av IFN-omega, og sett for bruk ved paavisningen
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
DE69631528D1 (de) Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum
AR224765A1 (es) Metodo controlado para el fraccionamiento rapido de proteinas del plasma sanguineo y metodo para la concentracion de proteinas de dicho plasma
ATE63457T1 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
DE3771717D1 (de) Verbindungsverfahren zweier materialien.